INCB 018424-13C,15N2 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

As labelled racemic analogue of Ruxolitinib (R702000), rac-Ruxolitinib-13C,15N2 is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.

INCB 018424-13C,15N2 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

INCB 018424-13C,15N2 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
QUALITY CONTROL SOLUTIONS LTD.	0755-66853366; 13670046396	ORDERS@QCSRM.COM	China	24342	58
Guangzhou PI PI Biotech Inc	020-81716320 +86-13602409664	Sales@pipitech.com	China	3633	55
Chemsky (shanghai) International Co.,Ltd	021-50135380	shchemsky@sina.com	China	15402	60
Hubei Yangxin Medical Technology Co., Ltd.	15374522761	3003392093@qq.com	China	8705	55
PI & PI BIOTECH INC.	020-81716320 17788709170	Sales@pipitech.com	China	2649	58
Nanjing Shizhou Biology Technology Co.,Ltd	17301488900	judy.xia@synzest.com	China	12582	58
TLC Pharmaceutical Standards Ltd.	18012923235	chinasales04@tlcstandards.com.cn	China	4921	58

---

• INCB 018424-13C,15N2
• rac-Ruxolitinib-13C,15N2
• β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazole-1-propanenitrile
• INCB 018424-d8
• rac-Ruxolitinib-d8
• 1794791-38-0